↓ Skip to main content

Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase…

Overview of attention for article published in Frontiers in Pharmacology, August 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
3 Mendeley